10 results on '"Musk, Gabrielle C."'
Search Results
2. Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep
- Author
-
Hillman, Noah H., primary, Kothe, T. Brett, additional, Schmidt, Augusto F., additional, Kemp, Matthew W., additional, Royse, Emily, additional, Fee, Erin, additional, Salomone, Fabrizio, additional, Clarke, Michael W., additional, Musk, Gabrielle C., additional, and Jobe, Alan H., additional
- Published
- 2020
- Full Text
- View/download PDF
3. Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep
- Author
-
Kothe, T. Brett, primary, Kemp, Matthew W., additional, Schmidt, Augusto, additional, Royse, Emily, additional, Salomone, Fabrizio, additional, Clarke, Michael W., additional, Musk, Gabrielle C., additional, Jobe, Alan H., additional, and Hillman, Noah H., additional
- Published
- 2019
- Full Text
- View/download PDF
4. Improving pregnancy outcomes in humans through studies in sheep
- Author
-
Morrison, Janna L., primary, Berry, Mary J., additional, Botting, Kimberley J., additional, Darby, Jack R. T., additional, Frasch, Martin G., additional, Gatford, Kathryn L., additional, Giussani, Dino A., additional, Gray, Clint L., additional, Harding, Richard, additional, Herrera, Emilio A., additional, Kemp, Matthew W., additional, Lock, Mitchell C., additional, McMillen, I. Caroline, additional, Moss, Timothy J., additional, Musk, Gabrielle C., additional, Oliver, Mark H., additional, Regnault, Timothy R. H., additional, Roberts, Claire T., additional, Soo, Jia Yin, additional, and Tellam, Ross L., additional
- Published
- 2018
- Full Text
- View/download PDF
5. Effects of budesonide and surfactant in preterm fetal sheep
- Author
-
Kothe, T. Brett, primary, Royse, Emily, additional, Kemp, Matthew W., additional, Schmidt, Augusto, additional, Salomone, Fabrizio, additional, Saito, Masatoshi, additional, Usuda, Haruo, additional, Watanabe, Shimpei, additional, Musk, Gabrielle C., additional, Jobe, Alan H., additional, and Hillman, Noah H., additional
- Published
- 2018
- Full Text
- View/download PDF
6. Antenatal creatine supplementation reduces persistent fetal lung inflammation and oxidative stress in an ovine model of chorioamnionitis.
- Author
-
Choi YJ, Williams E, Dahl MJ, Amos SE, James C, Bautista AP, Kurup V, Musk GC, Kershaw H, Arthur PG, Kicic A, Choi YS, Terrill JR, and Pillow JJ
- Subjects
- Animals, Female, Pregnancy, Sheep, Pneumonia metabolism, Pneumonia prevention & control, Pneumonia drug therapy, Pneumonia pathology, Disease Models, Animal, Fetus metabolism, Fetus drug effects, Chorioamnionitis drug therapy, Chorioamnionitis metabolism, Chorioamnionitis pathology, Creatine pharmacology, Oxidative Stress drug effects, Lung drug effects, Lung metabolism, Lung pathology, Dietary Supplements, Lipopolysaccharides
- Abstract
Chorioamnionitis is a common antecedent of preterm birth and induces inflammation and oxidative stress in the fetal lungs. Reducing inflammation and oxidative stress in the fetal lungs may improve respiratory outcomes in preterm infants. Creatine is an organic acid with known anti-inflammatory and antioxidant properties. The objective of the study was to evaluate the efficacy of direct fetal creatine supplementation to reduce inflammation and oxidative stress in fetal lungs arising from an in utero proinflammatory stimulus. Fetal lambs ( n = 51) were instrumented at 90 days gestation to receive a continuous infusion of creatine monohydrate (6 mg·kg
-1 ·h-1 ) or saline for 17 days. Maternal chorioamnionitis was induced with intra-amniotic lipopolysaccharide (LPS; 1 mg, O55:H6) or saline 7 days before delivery at 110 days gestation. Tissue creatine content was assessed with capillary electrophoresis, and inflammatory markers were analyzed with Luminex Magpix and immunohistochemistry. Oxidative stress was measured as the level of protein thiol oxidation. The effects of LPS and creatine were analyzed using a two-way ANOVA. Fetal creatine supplementation increased lung creatine content by 149% ( PCr < 0.0001) and had no adverse effects on lung morphology. LPS-exposed groups showed increased levels of interleukin-8 in the bronchoalveolar lavage ( PLPS < 0.0001) and increased levels of CD45+ leukocytes ( PLPS < 0.0001) and MPO+ ( PLPS < 0.0001) cells in the lung parenchyma. Creatine supplementation significantly reduced the levels of CD45+ ( PCr = 0.045) and MPO+ cells ( PCr = 0.012) in the lungs and reduced thiol oxidation in plasma ( PCr < 0.01) and lung tissue ( PCr = 0.02). In conclusion, fetal creatine supplementation reduced markers of inflammation and oxidative stress in the fetal lungs arising from chorioamnionitis. NEW & NOTEWORTHY We evaluated the effect of antenatal creatine supplementation to reduce pulmonary inflammation and oxidative stress in the fetal lamb lungs arising from lipopolysaccharide (LPS)-induced chorioamnionitis. Fetal creatine supplementation increased lung creatine content and had no adverse effects on systemic fetal physiology and overall lung architecture. Importantly, fetuses that received creatine had significantly lower levels of inflammation and oxidative stress in the lungs, suggesting an anti-inflammatory and antioxidant benefit of creatine.- Published
- 2024
- Full Text
- View/download PDF
7. Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep.
- Author
-
Hillman NH, Kothe TB, Schmidt AF, Kemp MW, Royse E, Fee E, Salomone F, Clarke MW, Musk GC, and Jobe AH
- Subjects
- Animals, Animals, Newborn metabolism, Cytokines metabolism, Female, Gestational Age, Humans, Infant, Newborn, Liver drug effects, Liver metabolism, Lung metabolism, Lung Injury metabolism, Pneumonia drug therapy, Pneumonia metabolism, Positive-Pressure Respiration methods, Pregnancy, Premature Birth metabolism, RNA, Messenger metabolism, Respiration drug effects, Sheep, Tidal Volume drug effects, Budesonide pharmacology, Lung drug effects, Lung Injury drug therapy, Pulmonary Surfactants pharmacology, Respiration, Artificial adverse effects
- Abstract
Mechanical ventilation from birth with normal tidal volumes (V
T ) causes lung injury and systemic responses in preterm sheep. The addition of budesonide to surfactant therapy decreases these injury markers. Budesonide and surfactant will decrease the injury from injurious VT ventilation in preterm sheep. Lambs at 126 ± 1 day gestational age were ventilated from birth with either: 1) Normal VT [surfactant 200 mg/kg before ventilation, positive end expiratory pressure (PEEP) 5 cmH2 O, VT 8 mL/kg] or 2) Injury VT (high pressure, 100% oxygen, no PEEP) for 15 min, then further randomized to surfactant + saline or surfactant + 0.25 mg/kg budesonide with Normal VT for 6 h. Lung function and lung, liver, and brain tissues were evaluated for indicators of injury. Injury VT + saline caused significant injury and systemic responses, and Injury VT + budesonide improved lung physiology. Budesonide decreased lung inflammation and decreased pro-inflammatory cytokine mRNA in the lung, liver, and brain to levels similar to Normal VT + saline. Budesonide was present in plasma within 15 min of treatment in both ventilation groups, and less than 5% of the budesonide remained in the lung at 6 h. mRNA sequencing of liver and periventricular white matter demonstrated multiple pathways altered by both Injury VT and budesonide and the combination exposure. In lambs receiving Injury VT , the addition of budesonide to surfactant improved lung physiology and decreased pro-inflammatory cytokine responses in the lung, liver, and brain to levels similar to lambs receiving Normal VT .- Published
- 2020
- Full Text
- View/download PDF
8. Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep.
- Author
-
Kothe TB, Kemp MW, Schmidt A, Royse E, Salomone F, Clarke MW, Musk GC, Jobe AH, and Hillman NH
- Subjects
- Animals, Animals, Newborn, Brain metabolism, Brain pathology, Brain physiopathology, Inflammation metabolism, Inflammation pathology, Inflammation physiopathology, Inflammation therapy, Liver metabolism, Liver pathology, Liver physiopathology, Sheep, Budesonide pharmacokinetics, Budesonide pharmacology, Lung metabolism, Lung pathology, Lung physiopathology, Pneumonia metabolism, Pneumonia pathology, Pneumonia physiopathology, Pneumonia therapy, Pulmonary Surfactants pharmacokinetics, Pulmonary Surfactants pharmacology, Respiration, Artificial
- Abstract
Mechanical ventilation with normal tidal volumes (V
T ) causes lung and systemic inflammation in preterm sheep. Mechanical ventilation is associated with bronchopulmonary dysplasia (BPD) in preterm infants, and the addition of budesonide to surfactant decreases BPD in clinical trials. Budesonide with surfactant will decrease the lung injury from mechanical ventilation for 24 h in preterm sheep. Lambs at 126 ± 1 day gestational age were delivered and randomized to either: 1 ) surfactant (200 mg/kg) or 2 ) surfactant mixed with budesonide (0.25 mg/kg) before mechanical ventilation with VT of 7-8 ml/kg for 2, 6, or 24 h ( n = 6 or 7/group). Lung physiology and budesonide levels in the plasma and the lung were measured. Lung tissue, bronchoalveolar lavage fluid (BALF), liver, and brain tissues were evaluated for indicators of injury. High initial budesonide plasma levels of 170 ng/ml decreased to 3 ng/ml at 24 h. Lung tissue budesonide levels were less than 1% of initial dose by 24 h. Although physiological variables were generally similar, budesonide-exposed lambs required lower mean airway pressures, had higher hyperoxia responses, and had more stable blood pressures. Budesonide decreased proinflammatory mRNA in the lung, liver, and brain. Budesonide also decreased total protein and proinflammatory cytokines in BALF, and decreased inducible nitric oxide synthase activation at 24 h. In ventilated preterm lambs, most of the budesonide left the lung within 24 h. The addition of budesonide to surfactant improved physiology, decreased markers of lung injury, and decreased systemic responses in liver and brain.- Published
- 2019
- Full Text
- View/download PDF
9. Improving pregnancy outcomes in humans through studies in sheep.
- Author
-
Morrison JL, Berry MJ, Botting KJ, Darby JRT, Frasch MG, Gatford KL, Giussani DA, Gray CL, Harding R, Herrera EA, Kemp MW, Lock MC, McMillen IC, Moss TJ, Musk GC, Oliver MH, Regnault TRH, Roberts CT, Soo JY, and Tellam RL
- Subjects
- Animals, Disease Models, Animal, Female, Humans, Maternal-Fetal Exchange physiology, Pregnancy, Pregnancy, Animal, Fetus metabolism, Placenta metabolism, Pregnancy Outcome, Sheep physiology
- Abstract
Experimental studies that are relevant to human pregnancy rely on the selection of appropriate animal models as an important element in experimental design. Consideration of the strengths and weaknesses of any animal model of human disease is fundamental to effective and meaningful translation of preclinical research. Studies in sheep have made significant contributions to our understanding of the normal and abnormal development of the fetus. As a model of human pregnancy, studies in sheep have enabled scientists and clinicians to answer questions about the etiology and treatment of poor maternal, placental, and fetal health and to provide an evidence base for translation of interventions to the clinic. The aim of this review is to highlight the advances in perinatal human medicine that have been achieved following translation of research using the pregnant sheep and fetus.
- Published
- 2018
- Full Text
- View/download PDF
10. Effects of budesonide and surfactant in preterm fetal sheep.
- Author
-
Kothe TB, Royse E, Kemp MW, Schmidt A, Salomone F, Saito M, Usuda H, Watanabe S, Musk GC, Jobe AH, and Hillman NH
- Subjects
- Animals, Female, Liver metabolism, Liver pathology, Liver physiopathology, Lung metabolism, Lung pathology, Lung physiopathology, Pregnancy, Premature Birth metabolism, Premature Birth pathology, Premature Birth physiopathology, Respiration, Artificial adverse effects, Respiration, Artificial methods, Sheep, Bronchopulmonary Dysplasia metabolism, Bronchopulmonary Dysplasia pathology, Bronchopulmonary Dysplasia physiopathology, Bronchopulmonary Dysplasia therapy, Budesonide pharmacokinetics, Budesonide pharmacology, Fetus metabolism, Fetus pathology, Fetus physiopathology, Premature Birth therapy, Pulmonary Surfactants pharmacokinetics, Pulmonary Surfactants pharmacology
- Abstract
Mechanical ventilation causes lung injury and systemic inflammatory responses in preterm sheep and is associated with bronchopulmonary dysplasia (BPD) in preterm infants. Budesonide added to surfactant decreased BPD by 20% in infants. We wanted to determine the effects of budesonide and surfactant on injury from high tidal volume (V
T ) ventilation in preterm lambs. Ewes at 125 ± 1 days gestational age had fetal surgery to expose fetal head and chest with placental circulation intact. Lambs were randomized to 1) mechanical ventilation with escalating VT to target 15 ml/kg by 15 min or 2) continuous positive airway pressure (CPAP) of 5 cmH2 O. After the 15-min intervention, lambs were given surfactant 100 mg/kg with saline, budesonide 0.25 mg/kg, or budesonide 1 mg/kg. The fetuses were returned to the uterus for 24 h and then delivered and ventilated for 30 min to assess lung function. Budesonide levels were low in lung and plasma. CPAP groups had improved oxygenation, ventilation, and decreased injury markers compared with fetal VT lambs. Budesonide improved ventilation in CPAP lambs. Budesonide decreased lung weights and lung liquid and increased lung compliance and surfactant protein mRNA. Budesonide decreased proinflammatory and acute-phase responses in lung. Airway thickness increased in animals not receiving budesonide. Systemically, budesonide decreased monocyte chemoattractant protein-1 mRNA and preserved glycogen in liver. Results with 0.25 and 1 mg/kg budesonide were similar. We concluded that budesonide with surfactant matured the preterm lung and decreased the liver responses but did not improve lung function after high VT injury in fetal sheep.- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.